Long-term follow-up on the effects of sodium oxybate on daytime sleepiness and sleep architecture in patients with narcolepsy type 1

INTRODUCTION. Sodium oxybate (SXB) was administered for the first time in 1979 in 16 patients with narcolepsy with cataplexy (NT1) that improved up to 20 months. AIMS. To evaluate the effect of SXB on daytime sleepiness and sleep architecture by video-polysomnography in a sample of 23 NT1 adult pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Peraita-Adrados, Rosa, Bellón, José M., Lillo-Triguero, Laura, López-Esteban, Pilar, Medrano-Martínez, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Viguera Editores (Evidenze Group) 2023
Materias:
Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364034/
https://www.ncbi.nlm.nih.gov/pubmed/36631962
http://dx.doi.org/10.33588/rn.7602.2022315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364034/
https://www.ncbi.nlm.nih.gov/pubmed/36631962
http://dx.doi.org/10.33588/rn.7602.2022315

Ejemplares similares